PA8796201A1 - Agentes anti-infecciosos y su uso - Google Patents

Agentes anti-infecciosos y su uso

Info

Publication number
PA8796201A1
PA8796201A1 PA20088796201A PA8796201A PA8796201A1 PA 8796201 A1 PA8796201 A1 PA 8796201A1 PA 20088796201 A PA20088796201 A PA 20088796201A PA 8796201 A PA8796201 A PA 8796201A PA 8796201 A1 PA8796201 A1 PA 8796201A1
Authority
PA
Panama
Prior art keywords
salts
compounds
compositions
infective agents
methods
Prior art date
Application number
PA20088796201A
Other languages
English (en)
Inventor
Wagner Rolf
D Tufano Michael
D Stewart Kent
W Rockway Todd
T Randolph John
K Pratt John
E Motter Christopher
J Maring Clarence
L Longenecker Kenton
Liu Yaya
Liu Dachun
C Krueger Allan
M Kati Warren
K Hutchinson Douglas
P Huang Peggy
A Flentge Charles
L Donner Pamela
A Degoey David
A Betebenner David
M Barnes David
Chen Shuang
S Franczyk Ii Thaddeus
Gao Yi
R Haight Anthony
E Hengeveld John
F Henry Rodger
J Kotecki Brian
Lou Xiaochun
Sarris Kathy
G Z Zhang Geoff
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39948002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8796201(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PA8796201A1 publication Critical patent/PA8796201A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

ESTA INVENCIÓN SE RELACIONA CON: (A) COMPUESTOS Y SALES DE LOS MISMOS QUE, ENTRE OTROS, INHIBEN EL HCV; (B) INTERMEDIARIOS DE UTILIDAD PARA LA PREPARACIÓN DE DICHOS COMPUESTOS Y SALES; (C) COMPOSICIONES QUE COMPRENDEN DICHOS COMPUESTOS Y SALES; (D) MÉTODOS PARA PREPARAR DICHOS INTERMEDIARIOS, COMPUESTOS, SALES Y COMPOSICIONES; (E) MÉTODOS DE USO DE DICHOS COMPUESTOS, SALES Y COMPOSICIONES; Y (F) CONJUNTOS DE ELEMENTOS QUE COMPRENDEN DICHOS COMPUESTOS, SALES Y COMPOSICIONES.
PA20088796201A 2007-09-17 2008-09-17 Agentes anti-infecciosos y su uso PA8796201A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97287707P 2007-09-17 2007-09-17
US9679108P 2008-09-13 2008-09-13

Publications (1)

Publication Number Publication Date
PA8796201A1 true PA8796201A1 (es) 2009-04-23

Family

ID=39948002

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088796201A PA8796201A1 (es) 2007-09-17 2008-09-17 Agentes anti-infecciosos y su uso

Country Status (31)

Country Link
US (3) US8415351B2 (es)
EP (2) EP2222646B1 (es)
JP (2) JP5734654B2 (es)
KR (2) KR101552474B1 (es)
CN (2) CN102746239B (es)
AR (2) AR070027A1 (es)
AU (1) AU2008302448B2 (es)
BR (1) BRPI0816994B8 (es)
CA (2) CA2699981C (es)
CL (2) CL2008002794A1 (es)
CO (1) CO6260076A2 (es)
CR (2) CR11316A (es)
DO (2) DOP2010000084A (es)
ES (1) ES2453591T3 (es)
GT (1) GT201000061A (es)
HK (1) HK1147256A1 (es)
IL (1) IL204547A (es)
IN (1) IN2012DN05113A (es)
MX (2) MX2010002905A (es)
MY (1) MY162760A (es)
NZ (3) NZ618277A (es)
PA (1) PA8796201A1 (es)
PE (2) PE20130209A1 (es)
PH (1) PH12013500365A1 (es)
RU (2) RU2543620C2 (es)
SG (1) SG183733A1 (es)
TW (2) TWI534137B (es)
UA (1) UA117800C2 (es)
UY (1) UY31344A1 (es)
WO (1) WO2009039127A1 (es)
ZA (2) ZA201204223B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010002904A (es) 2007-09-17 2010-06-02 Abbott Lab N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
SG183733A1 (en) 2007-09-17 2012-09-27 Abbott Lab Uracil or thymine derivative for treating hepatitis c
ATE519746T1 (de) 2007-09-17 2011-08-15 Abbott Lab Antiinfektiöse pyrimidine und anwendungen davon
JP5249344B2 (ja) * 2007-11-16 2013-07-31 メルク・シャープ・アンド・ドーム・コーポレーション ヘテロ環の３位が置換されたインドール誘導体およびその使用
CN102099335A (zh) 2008-07-23 2011-06-15 弗·哈夫曼-拉罗切有限公司 杂环抗病毒化合物
JP2012503620A (ja) 2008-09-26 2012-02-09 エフ．ホフマン−ラ ロシュ アーゲー Ｈｃｖを処置するためのピリンまたはピラジン誘導体
CN102361858B (zh) * 2009-03-24 2014-07-23 艾伯维巴哈马有限公司 制备抗病毒化合物的方法
RU2552533C2 (ru) * 2009-03-25 2015-06-10 Эббви Инк. Противовирусные соединения и их применения
WO2010111653A2 (en) * 2009-03-27 2010-09-30 The Uab Research Foundation Modulating ires-mediated translation
SG175774A1 (en) 2009-04-25 2011-12-29 Hoffmann La Roche Heterocyclic antiviral compounds
AR077004A1 (es) 2009-06-09 2011-07-27 Hoffmann La Roche Compuestos heterociclicos antivirales
TW201103545A (en) * 2009-06-24 2011-02-01 Hoffmann La Roche Heterocyclic antiviral compound
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
AU2010297290A1 (en) 2009-09-21 2012-03-15 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
WO2011061243A1 (en) * 2009-11-21 2011-05-26 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
EP2513092A1 (en) 2009-12-14 2012-10-24 F. Hoffmann-La Roche AG Heterocyclic antiviral compounds
US9216952B2 (en) * 2010-03-23 2015-12-22 Abbvie Inc. Process for preparing antiviral compound
RU2572558C2 (ru) 2010-07-07 2016-01-20 Ф. Хоффманн-Ля Рош Аг Противовирусные гетероциклические соединения
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
BR112013001138A2 (pt) 2010-07-16 2016-07-05 Abbvie Inc ligantes de fosfina para reações catalíticas
KR101893751B1 (ko) 2010-07-16 2018-09-03 애브비 아일랜드 언리미티드 컴퍼니 항바이러스성 화합물의 제조 방법
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
AU2015201698B2 (en) * 2010-07-16 2017-02-02 Abbvie Ireland Unlimited Company Process for preparing antiviral compounds
RU2436786C1 (ru) * 2010-07-23 2011-12-20 Александр Васильевич Иващенко Замещенные индолы, противовирусный активный компонент, способ получения и применения
WO2012020725A1 (ja) * 2010-08-10 2012-02-16 塩野義製薬株式会社 Ｎｐｙ ｙ５受容体拮抗作用を有するヘテロ環誘導体
KR101382730B1 (ko) 2010-08-13 2014-04-08 에프. 호프만-라 로슈 아게 헤테로환형 항바이러스성 화합물
CN102675092B (zh) * 2011-03-14 2014-11-05 江苏中丹药物研究有限公司 一种制备2-芳基-2,2-二甲基乙酸甲酯的方法
US9248193B2 (en) 2011-03-18 2016-02-02 Abbvie Inc. Formulations of phenyl uracil compounds
EP2691118B1 (de) * 2011-03-31 2019-05-01 Schäfer, Konstanze Perfluorierte verbindungen zum nicht-viralen transfer von nukleinsäuren
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
JP5734124B2 (ja) * 2011-07-21 2015-06-10 株式会社 東邦アーステック １，３−ジヨードヒダントイン類の製造方法
CN104024241B (zh) 2011-08-01 2016-01-20 大日本住友制药株式会社 尿嘧啶衍生物和其用于医学目的的用途
US8853176B2 (en) 2011-10-21 2014-10-07 Abbvie Inc. Methods for treating HCV
AU2015200715A1 (en) * 2011-10-21 2015-03-05 Abbvie Ireland Unlimited Company Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
GB2515942A (en) 2011-10-21 2015-01-07 Abbvie Inc Combination treatment (e.g. with ABT-072 or ABT-333) of DAAs for use in treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
DK2861579T5 (da) 2012-05-15 2022-10-24 Novartis Ag Benzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1
CA2871715A1 (en) 2012-05-15 2013-11-21 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
US9315489B2 (en) 2012-05-15 2016-04-19 Novartis Ag Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
CA2871332A1 (en) 2012-05-15 2013-11-21 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
EP2866807A2 (en) 2012-06-27 2015-05-06 Abbvie Inc. Methods for treating hcv
CN104884440A (zh) * 2012-08-21 2015-09-02 艾伯维公司 用于制备抗病毒化合物的方法
CN104853752B (zh) 2012-10-18 2018-10-23 艾伯维公司 嘧啶二酮衍生物化合物的制剂
JP2014101316A (ja) * 2012-11-20 2014-06-05 Toyobo Co Ltd ベンゾ［１，２−ｄ；４，５−ｄ’］ビスチアゾール化合物の製造方法
EP3016651A1 (en) 2013-07-02 2016-05-11 AbbVie Inc. Methods for treating hcv
US9783509B2 (en) 2013-07-08 2017-10-10 Bayer Cropscience Aktiengesellschaft Six-membered C-N-linked aryl sulfide derivatives and aryl sulfoxide derivatives as pest conrol agents
TW201542581A (zh) 2013-09-11 2015-11-16 Univ Emory 核苷酸與核苷治療組成物及其相關用途
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
WO2015116594A1 (en) 2014-01-28 2015-08-06 Abbvie Inc. Dose adjustment in combination therapy of hepatitis c
WO2015116904A1 (en) 2014-02-03 2015-08-06 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ror-gamma
WO2015197028A1 (en) * 2014-06-28 2015-12-30 Sunshine Lake Pharma Co., Ltd. Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine
WO2016004513A1 (en) * 2014-07-11 2016-01-14 Simon Fraser University Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
DK3174868T3 (da) 2014-08-01 2021-11-08 Nuevolution As Forbindelser, der er aktive mod bromodomæner
WO2016040588A1 (en) 2014-09-11 2016-03-17 Abbvie Inc. Treatment of hcv by administering four different anti-hcv compounds with food
WO2016061160A1 (en) 2014-10-14 2016-04-21 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ror-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
WO2016105547A1 (en) 2014-12-24 2016-06-30 Concert Pharmaceuticals, Inc. Deuterated dasabuvir
RU2590952C1 (ru) * 2015-05-26 2016-07-10 Вячеслав Энгельсович Семёнов Средство гепатопротекторного действия
WO2016196280A1 (en) 2015-06-02 2016-12-08 E I Du Pont De Nemours And Company Heterocycle-substituted bicyclic pesticides
EP3328839A1 (en) * 2015-07-30 2018-06-06 Bristol-Myers Squibb Company Aryl substituted bicyclic heteroaryl compounds
ES2856931T3 (es) 2015-08-05 2021-09-28 Vitae Pharmaceuticals Llc Moduladores de ROR-gamma
RU2018121946A (ru) 2015-11-20 2019-12-23 Вайтаи Фармасьютиклз, Ллк Модуляторы ror-гамма
TW202220968A (zh) 2016-01-29 2022-06-01 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
WO2017189978A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
MA49685A (fr) 2017-07-24 2021-04-14 Vitae Pharmaceuticals Llc INHIBITEURS DE ROR gamma
CN107266373A (zh) * 2017-08-01 2017-10-20 安徽拜善晟制药有限公司 一种原料药达沙布韦的制备方法
CN110483496B (zh) * 2019-07-17 2021-05-04 杭州市西溪医院 一类具有尿嘧啶-苯并噻唑结构衍生物、其制备方法及抗hcv药物的应用
EP3819006A1 (en) 2019-11-05 2021-05-12 Technische Universität Dresden Compounds with thymine skeleton for use in medicine
CN111518036A (zh) * 2020-04-29 2020-08-11 杭州勇诚睿生物科技有限公司 一种达沙布韦关键中间体的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239888A (en) * 1974-11-04 1980-12-16 Pfizer Inc. 1-Phenyluracils
JPS60243017A (ja) * 1984-05-16 1985-12-03 Kyowa Hakko Kogyo Co Ltd 抗けいれん組成物
US5084084A (en) * 1989-07-14 1992-01-28 Nissan Chemical Industries Ltd. Uracil derivatives and herbicides containing the same as active ingredient
AU627906B2 (en) * 1989-07-14 1992-09-03 Nissan Chemical Industries Ltd. Uracil derivatives and herbicides containing the same as active ingredient
US5162326A (en) 1990-02-15 1992-11-10 Takeda Chemical Industries, Ltd. Pyrimidinedione derivatives, their production and use
NL9001075A (es) * 1990-05-04 1991-12-02 Duphar Int Res
EP0489480A1 (en) * 1990-12-05 1992-06-10 Nissan Chemical Industries Ltd. Uracil derivatives and herbicides containing the same as active ingredient
JPH05213755A (ja) 1992-02-07 1993-08-24 Nikko Kyodo Co Ltd 肝臓障害治療薬
DE19528305A1 (de) 1995-08-02 1997-02-06 Bayer Ag Substituierte Phenyluracile
US6380387B1 (en) * 1999-12-06 2002-04-30 Hoffmann-La Roche Inc. 4-Pyrimidinyl-n-acyl-l phenylalanines
WO2001042225A2 (en) 1999-12-06 2001-06-14 F. Hoffmann-La Roche Ag 4-pyrimidinyl-n-acyl-l-phenylalanines
RU2264395C2 (ru) * 2000-02-04 2005-11-20 Сумитомо Кемикал Компани, Лимитед Производные урацила, гербицидная композиция, способ борьбы с сорняками и промежуточные продукты (варианты)
IL141034A0 (en) * 2000-02-04 2002-02-10 Sumitomo Chemical Co Uracil compounds and use thereof
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
KR100589964B1 (ko) * 2003-06-13 2006-06-19 주식회사 엘지생명과학 Ｃ형 간염 바이러스의 억제제
US7163937B2 (en) 2003-08-21 2007-01-16 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
TWI394747B (zh) * 2006-06-23 2013-05-01 Smithkline Beecham Corp 脯胺醯基羥化酶抑制劑
ATE519746T1 (de) 2007-09-17 2011-08-15 Abbott Lab Antiinfektiöse pyrimidine und anwendungen davon
MX2010002904A (es) 2007-09-17 2010-06-02 Abbott Lab N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
SG183733A1 (en) * 2007-09-17 2012-09-27 Abbott Lab Uracil or thymine derivative for treating hepatitis c
CN102099335A (zh) 2008-07-23 2011-06-15 弗·哈夫曼-拉罗切有限公司 杂环抗病毒化合物

Also Published As

Publication number Publication date
AU2008302448A1 (en) 2009-03-26
AU2008302448B2 (en) 2014-11-06
CO6260076A2 (es) 2011-03-22
RU2013104270A (ru) 2014-08-10
CR20150238A (es) 2015-07-01
ZA201204224B (en) 2015-12-23
DOP2010000396A (es) 2013-12-31
KR20100068289A (ko) 2010-06-22
JP2013049681A (ja) 2013-03-14
TWI534137B (zh) 2016-05-21
IN2012DN05113A (es) 2015-10-23
WO2009039127A1 (en) 2009-03-26
CN102746239A (zh) 2012-10-24
GT201000061A (es) 2012-03-26
UY31344A1 (es) 2009-04-30
MX338555B (es) 2016-04-20
RU2543620C2 (ru) 2015-03-10
CL2008002794A1 (es) 2009-09-04
BRPI0816994B8 (pt) 2021-05-25
MY162760A (en) 2017-07-14
NZ584720A (en) 2012-07-27
CN102746239B (zh) 2016-02-10
IL204547A (en) 2016-04-21
AR087472A2 (es) 2014-03-26
KR20150117632A (ko) 2015-10-20
CL2013000372A1 (es) 2013-10-04
BRPI0816994B1 (pt) 2019-12-24
US9095590B2 (en) 2015-08-04
CR11316A (es) 2010-10-05
EP2725015A1 (en) 2014-04-30
KR101660360B1 (ko) 2016-09-27
RU2010114828A (ru) 2011-10-27
TW200918066A (en) 2009-05-01
BRPI0816994A2 (pt) 2015-03-24
KR101552474B1 (ko) 2015-09-11
TWI437994B (zh) 2014-05-21
ZA201204223B (en) 2015-12-23
PH12013500365A1 (en) 2014-09-08
US8685991B2 (en) 2014-04-01
PE20090705A1 (es) 2009-07-17
US8415351B2 (en) 2013-04-09
JP5734654B2 (ja) 2015-06-17
CN101801935A (zh) 2010-08-11
DOP2010000084A (es) 2010-06-15
US20110070193A1 (en) 2011-03-24
EP2222646B1 (en) 2014-01-22
PE20130209A1 (es) 2013-03-24
ES2453591T3 (es) 2014-04-08
SG183733A1 (en) 2012-09-27
AR070027A1 (es) 2010-03-10
EP2222646A1 (en) 2010-09-01
NZ618277A (en) 2015-07-31
CN101801935B (zh) 2014-12-03
CA2976793A1 (en) 2009-03-26
CA2699981A1 (en) 2009-03-26
HK1147256A1 (en) 2011-08-05
IL204547A0 (en) 2010-11-30
TW201443027A (zh) 2014-11-16
NZ600371A (en) 2014-07-25
MX2010002905A (es) 2010-07-05
RU2599635C2 (ru) 2016-10-10
CA2699981C (en) 2017-08-22
JP2010539186A (ja) 2010-12-16
US20140235638A1 (en) 2014-08-21
US20120213733A1 (en) 2012-08-23
UA117800C2 (uk) 2018-10-10

Similar Documents

Publication Publication Date Title
PA8796201A1 (es) Agentes anti-infecciosos y su uso
CL2018002703A1 (es) Agentes de iarn, composiciones y métodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr). (divisional solicitud 201401291)
DOP2015000264A (es) Derivados de azaadamantano y métodos de uso de los mismos
UY31806A (es) Compuestos de tiazole y oxazole de sulfonamida de benceno
PA8693101A1 (es) Compuestos de isoindol-imida y composiciones que los incluyen y mètodos para su uso
UY29601A1 (es) Arilpirazoles sustituidos
CR20150088A (es) Anticuerpos anti-notch1 nrr
HN2012001162A (es) Triazolopiridinas
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
ECSP11011390A (es) Compuestos espiro-amidas sustituidas
UY29376A1 (es) Anilidas de ácido pirazolcarboxílico, un procedimiento para su obtencón y productos que contienen las mismas para combatir hongos nocivos.
UY29375A1 (es) 5-alcoxialquil-6-alquil-7-amino-azolopirimidinas, un procedimiento para su obtención y el uso de las mismas para combatir hongos nocivos,así como productos que las contienen.
GT200600144A (es) 1h-quinazolin-2,4-dionas
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
GT200900027A (es) Compuestos organicos
HN2008001464A (es) Formulaciones para administrcion parenteral de compuestos y sus usos
DOP2009000257A (es) Inhibidores de cinasa p70 s6
UY28708A1 (es) Heterociclos sustituídos y usos de los mismos
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
CL2008003690A1 (es) Compuestos derivados de amonobenzamida; composicion farmceutica que comprende los compuestos; y uso para controlar parasitos.
ECSP11011344A (es) Nuevos anticuerpos anti-?5?1 y sus usos
CR9786A (es) Compuestos de bencimidazol-tiofeno
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
GT200600025A (es) Pirazolopiridinas y sales de las mismas, una composicion farmaceutica que comprende dichos compuestos, un metodo para prepararlos y su uso
UY33037A (es) Compuestos benzoimidazólicos y sus usos